TE
REGN icon

Tema ETFs’s Regeneron Pharmaceuticals REGN Stock Holding History

Tema ETFs’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Buy
5,481
+121
+2% +$82.4K 0.11% 135
2026
Q1 		$4.14M Buy
5,360
+498
+10% +$381K 0.28% 93
2025
Q4 		$3.75M Sell
4,862
-509
-9% -$346K 0.29% 98
2025
Q3 		$3.02M Buy
5,371
+64
+1% +$36.2K 0.25% 121
2025
Q2 		$2.79M Buy
5,307
+1,007
+23% +$562K 0.74% 49
2025
Q1 		$2.73M Sell
4,300
-1,549
-26% -$1.07M 0.81% 41
2024
Q4 		$4.17M Buy
+5,849
New +$4.91M 1.73% 22

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Tema ETFs's REGN Position: Q2 2026 in Review

Tema ETFs increased its Regeneron Pharmaceuticals (REGN) stake by 2.3% in Q2 2026, buying an estimated $82.4K and bringing the position to 5,481 shares worth $3.42M. The position accounts for 0.11% of the portfolio, ranked #135.

Tema ETFs first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.17M in Q4 2024. 180 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Tema ETFs held 5,481 shares of Regeneron Pharmaceuticals worth $3.42M as of Q2 2026.
  • Tema ETFs bought 121 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $82.4K.
  • Regeneron Pharmaceuticals made up 0.11% of Tema ETFs's portfolio in Q2 2026, its #135 holding.
  • Tema ETFs first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Regeneron Pharmaceuticals position peaked at $4.17M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.